June 13th, 2023

Missfresh Limited (Nasdaq: MF) is facing the possibility of delisting from The Nasdaq Stock Market LLC ("Nasdaq") as notified by the Listing Qualifications Department.  In response, the company intends to request a hearing before the Nasdaq H. Read more

June 12th, 2023

Pratt and Whitney Military Engines, a Raytheon Technologies (NYSE: RTX) business, has been awarded a significant modification to a contract for the procurement of F-135 propulsion system spare parts and support equipment.  The firm-fixed-pric. Read more

June 12th, 2023

FOR IMMEDIATE RELEASE 2023-107 Washington D.C. / CRWE PRESS RELEASE / June 12, 2023  — The Securities and Exchange Commission today charged investment adviser Sabby Management LLC and its managing partner, Hal D. Mintz, with fraud in c. Read more

June 12th, 2023

iBio, Inc. (NYSE American: IBIO) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID) to explore the potential of the company's AI-driven epitope steering platform in developing a vaccine for Lassa fever, a severe and . Read more

June 12th, 2023

Nasdaq, Inc. (Nasdaq: NDAQ) has announced a definitive agreement to acquire Adenza, a leading provider of risk management and regulatory software to the financial services industry, from Thoma Bravo for a total consideration of $10.5 billion in cash . Read more

June 12th, 2023

Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more

June 12th, 2023

Advanced Micro Devices, Inc. (Nasdaq: AMD), a leading semiconductor company specializing in advanced computing and graphics technologies, saw its price target raised by KeyBanc from $110 to $150.  With $AMD closing at $124.92 on Friday, this . Read more

June 12th, 2023

Pharvaris N.V. (Nasdaq: PHVS) released data from their Phase 2 study, RAPIDe-1, evaluating the on-demand treatment of hereditary angioedema (HAE) attacks with PHVS416 (deucrictibant immediate-release capsules). The study showed that treatment with. Read more

June 11th, 2023

Intellia Therapeutics, Inc. (Nasdaq: NTLA) has shared updated interim results from the Phase 1 portion of their ongoing study of NTLA-2002, a CRISPR candidate for treating hereditary angioedema (HAE).  The company believes that the data reinf. Read more

June 10th, 2023

Thursday, June 15, will see several companies releasing their financial results, including: Adobe Inc. (Nasdaq: ADBE), a global leader in digital media and marketing solutions, is set to announce its second-quarter fiscal year 2023 results after t. Read more